WEKO3
アイテム
Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents : Analysis Based on the FDA Adverse Event Reporting System
https://tokushima-u.repo.nii.ac.jp/records/2000264
https://tokushima-u.repo.nii.ac.jp/records/20002647ce898fd-d949-4a5a-90eb-dd6212fa1e58
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
ofid_10_8_ofad414.pdf (709 KB)
|
.png)
|
| Item type | 文献 / Documents(1) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2024-11-11 | |||||||||||||||||||||||||
| アクセス権 | ||||||||||||||||||||||||||
| アクセス権 | open access | |||||||||||||||||||||||||
| アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||||||||||||||||||
| 資源タイプ | ||||||||||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||||||||||
| 出版社版DOI | ||||||||||||||||||||||||||
| 識別子タイプ | DOI | |||||||||||||||||||||||||
| 関連識別子 | https://doi.org/10.1093/ofid/ofad414 | |||||||||||||||||||||||||
| 言語 | ja | |||||||||||||||||||||||||
| 関連名称 | 10.1093/ofid/ofad414 | |||||||||||||||||||||||||
| 出版タイプ | ||||||||||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||||||||||
| タイトル | ||||||||||||||||||||||||||
| タイトル | Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents : Analysis Based on the FDA Adverse Event Reporting System | |||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 著者 |
Okada, Naoto
× Okada, Naoto
× 新村, 貴博
WEKO
1496
× Saisyo, Atsuyuki
× Kawaguchi, Yoshitaka
× 石澤, 啓介
WEKO
228
× Kitahara, Takashi
|
|||||||||||||||||||||||||
| 抄録 | ||||||||||||||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||||||||||||||
| 内容記述 | Background. Eosinophilic pneumonia (EP) is a rare adverse event caused by several types of drugs, such as antibiotics; however, its characteristics remain poorly described. This study aimed to analyze the disproportionality between the occurrence of EP and anti–methicillin-resistant Staphylococcus aureus (anti-MRSA) agents and to characterize anti-MRSA agent–induced EP events using the Food and Drug Administration Adverse Event Reporting System (FAERS). Method. Disproportionality linking EP and anti-MRSA agents was analyzed through bayesian confidence propagation neural networks of information components and reporting odds ratio methodologies. The FAERS data set for the fourth quarter of 2012 to the fourth quarter of 2022 was used. We also analyzed the characteristics of EP induced by anti-MRSA agents. Results. A total of 14 805 795 reports were obtained from FAERS. Disproportionality analysis revealed that the EP signal was detected only in cases with the administration of daptomycin (DAP). This disproportionality signal was consistently detected in the sensitivity analysis. When compared with other reports of DAP-related adverse events, the reports of DAP-related EP were characterized by male sex (odds ratio [OR], 1.94; 95% CI, 1.12–3.37), older age (>70 years; OR, 2.70; 95% CI, 1.68–4.33), and longer duration of treatment (>21 days; OR, 5.08; 95% CI, 3.21–8.05). Conclusions. This study revealed that among the anti-MRSA agents, disproportionality in the occurrence of EP was observed only with DAP. Our results suggest that sex, age, and treatment duration may affect the occurrence of DAP-induced EP. Clinicians should exercise caution regarding EP during DAP administration. |
|||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||||||
| 主題 | Adverse Event Reporting System | |||||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||||||
| 主題 | daptomycin | |||||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||||||
| 主題 | eosinophilic pneumonia | |||||||||||||||||||||||||
| 書誌情報 |
en : Open Forum Infectious Diseases 巻 10, 号 8, p. ofad414, 発行日 2023-08-02 |
|||||||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||||||
| 収録物識別子タイプ | EISSN | |||||||||||||||||||||||||
| 収録物識別子 | 23288957 | |||||||||||||||||||||||||
| 出版者 | ||||||||||||||||||||||||||
| 出版者 | Oxford University Press | |||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 権利情報 | ||||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||||
| 権利情報 | Creative Commons Attribution-NonCommercial-NoDerivs licence, which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. | |||||||||||||||||||||||||
| EID | ||||||||||||||||||||||||||
| 識別子 | 406563 | |||||||||||||||||||||||||
| 識別子タイプ | URI | |||||||||||||||||||||||||
| 言語 | ||||||||||||||||||||||||||
| 言語 | eng | |||||||||||||||||||||||||
